Acasti Pharma reported CAD3.57M in Operating Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Acasti Pharma ACST:US C$ 3.57M 1.15M
Addus Homecare ADUS:US $ 199.3M 1.54M
Agile Therapeutics AGRX:US 17.06M 775K
Amarin AMRN:US 155.11M 9.4M
Bioscrip BIOS:US $ 839.05M 26.87M
Genetic Technologies GENE:US $ 3.7M 215.91K
Pain Therapeutics PTIE:US $ 9.75M 4.62M